Overview

Levosimendan In Ambulatory Heart Failure Patients

Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The objective of the study is to determine the efficacy of repeated infusions of levosimendan in the group of outpatients with advanced systolic heart failure (HF).
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Bialystok
Collaborators:
Azienda Ospedaliera dei Colli
Institute of Cardiology, Warsaw, Poland
John Paul II Hospital, Krakow
Medical Research Agency
Medical University of Lodz
Medical Universtity of Lodz
Nicolaus Copernicus University
Poznan University of Medical Sciences
University of Opole
Treatments:
Simendan